Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Epidemiology And Natural History Of Benign Prostatic Hyperplasia.

M. Barry
Published 1990 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Benign prostatic hyperplasia (BPH) afflicts the majority of elderly men, and if current rates of surgery persist, the average 40-year-old man in the United States will have a 30 to 40 per cent chance of undergoing a prostatectomy if he survives to age 80. Age is by the far the most important determinant of BPH occurrence. Symptomatic BPH has a waxing and waning course, and a few men may have long-term remission. Surprisingly, the natural history of BPH is poorly defined, particularly with regard to the magnitude of the risks of its complications.



This paper is referenced by
Relación entre la dieta y el desarrollo de la hiperplasia prostática benigna
B. Arias (2010)
10.1200/JCO.2000.18.9.1942
Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors.
C. Moinpour (2000)
Title Effect of long-term administration of finasteride ( MK-906 ) , an inhibitor of 5 alpha-reductase , in patients with benign prostatic hyperplasia
O. Yoshida (2018)
Manganese superoxide dismutase ( Mn-SOD ) genic expression in tissue with prostate cancer and benign prostatic hyperplasia
Floriano-Sánchez (2010)
10.1016/S0302-2838(02)00319-6
Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
T. Shah (2002)
10.1007/S11934-002-0047-Y
Medical therapy for benign prostatic hyperplasia progression
K. McVary (2002)
10.1248/JHS.47.192
Investigation of the Effects of Tamsulosin on Blood Pressure in Normotensive, Controlled Hypertensive, and Uncontrolled Hypertensive Men with Benign Prostatic Hyperplasia
Kenji Yasukawa (2001)
10.11606/T.5.2004.TDE-19032007-132343
Resultados do estudo urodinâmico em pacientes diabéticos com sintomas do trato urinário inferior e aumento prostático
Paulo Tadeu Dib (2004)
10.1007/978-1-59259-644-7_1
Prostate Anatomy and Causative Theories, Pathophysiology, and Natural History of Benign Prostatic Hyperplasia
J. A. Stern (2004)
10.4236/OJPATHOLOGY.2016.63015
Quantitative Stereological Estimations of Structural Patterns of the Glandular Tree in Benign Hyperplasia of Prostate
L. Santamaría (2016)
Determinación de la expresión de la sintasa de óxido nítrico endotelial (eNOS) en tejidos con cáncer de próstata y en hiperplasia prostática benigna
E. Floriano-Sánchez (2010)
10.1117/12.239991
Transurethral radio frequency ablation of the prostate
J. Kabalin (1996)
10.4065/70.1.28
Visual laser ablation of the prostate: a preliminary report.
R. Malek (1995)
10.1007/978-4-431-68444-2_3
Transurethral Microwave Thermotherapy
M. Wildt (2000)
prostatectomy . audit of process and outcome of The feasibility and cost of a large multicentre
M. Emberton ()
10.1089/END.1997.11.467
Role of temporary stents in alternative treatment of benign prostatic hyperplasia.
J. de la Rosette (1997)
10.1016/S0950-351X(98)80008-6
6Phytoestrogens and diseases of the prostate gland
K. Griffiths (1998)
10.1007/BF00942041
Histomorphological changes after neodymium: YAG laser-coagulation of the human prostate with the Side Focus fiber
T. Sulser (2004)
10.3109/00365599609181313
Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. The ALFECH Study Group.
B. J. Hansen (1996)
10.1016/S0022-5347(06)00568-4
Correlation between serum prostate specific antigen and prostate volume in Taiwanese men with biopsy proven benign prostatic hyperplasia.
Yu-Lung Chang (2006)
10.1159/000071089
A Prospective Randomized Study of Combined Visual Laser Ablation and Transurethral Resection of the Prostate versus Transurethral Prostatectomy Alone
B. Planz (2003)
Efficacy and Safety of Doxazosin (CARDURA ) in the Management of Benign Prostatic Hyperplasia
E. Jeje (2011)
Application of the Chinese version of the International Prostate Symptom Score for the management of lower urinary tract symptoms in a primary health care setting
P. Abrams (2008)
10.1016/j.jval.2015.04.002
The Continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction.
J. Thomas (2015)
10.1007/978-3-642-78826-0_12
Natural History of Untreated Benign Prostatic Hyperplasia
M. Barry (1995)
10.1007/s003300050621
CT and MRI of the male genital tract: radiologic–pathologic correlation
R. Kubik-Huch (1999)
10.1016/S0090-4295(98)00069-7
Voiding dysfunction in benign prostatic hyperplasia: trends, controversies and recent revelations. II. Pathology and pathophysiology.
A. Elbadawi (1998)
10.1177/153537020122601012
Effect of Epristeride on the Expression of IGF-1 and TGF-β Receptors in Androgen-Induced Castrated Rat Prostate
S. Wu (2001)
10.1016/J.FJS.2014.10.001
Natural history and epidemiology of benign prostatic hyperplasia
S. Lu (2014)
10.1016/S0090-4295(99)80248-9
Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community.
J. R. Bosch (1995)
10.1007/BF00183619
Durability of laser fibers
E. T. Slaa (2004)
Niveles de expresión de Mn-superóxido dismutasa (Mn-SOD) en tejidos con cáncer de próstata e hiperplasia prostática benigna
Floriano-Sánchez Esaú (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar